Drug General Information |
Drug ID |
D03YVR
|
Former ID |
DPR000150
|
Drug Name |
Oxamflatin
|
Synonyms |
NSC729360; CHEBI:258842; I14-11718; NCGC00165855-01; (2E)-5-(3-(phenylsulfonylamino)phenyl)pent-2-ene-4-ynohydroxamic acid; (2E)-5-[3-(Phenylsulfonylamino)phenyl]pent-2-en-4-ynohydroxamic Acid; (E)-5-[3-(benzenesulfonamido)phenyl]-N-hydroxypent-2-en-4-ynamide; 151720-43-3
|
Drug Type |
Small molecular drug
|
Therapeutic Class |
Anticancer Agents
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C17H14N2O4S
|
Canonical SMILES |
C1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC(=C2)C#CC=CC(=O)NO
|
InChI |
1S/C17H14N2O4S/c20-17(18-21)12-5-4-7-14-8-6-9-15(13-14)19-24(22,23)16-10-2-1-3-11-16/h1-3,5-6,8-13,19,21H,(H,18,20)/b12-5+
|
InChIKey |
QRPSQQUYPMFERG-LFYBBSHMSA-N
|
PubChem Compound ID |
|
PubChem Substance ID |
11651402, 12015067, 14924949, 26759301, 29217613, 39379766, 48428190, 52944410, 57361597, 76715576, 99375465, 104026127, 113909785, 121379644, 131299952, 135360538, 142692368, 152039134, 162248411, 163687550, 164763887, 175608107, 177748467, 188919917, 204362425, 227462876, 227462878, 242084443, 250136914, 252355618, 252468845
|
Target and Pathway |
References |